Open AccessHigh-dose rifaximin treatment alleviates global symptoms of irritable bowel syndrome
Author(s) -
Jolley
Publication year - 2011
Publication title -
clinical and experimental gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.113
H-Index - 30
ISSN - 1178-7023
DOI - 10.2147/ceg.s18051
Subject(s) - rifaximin , irritable bowel syndrome , medicine , lactulose , gastroenterology , small intestinal bacterial overgrowth , antibiotics , microbiology and biotechnology , biology
To evaluate the efficacy of rifaximin for reduction of gastrointestinal symptoms in patients with irritable bowel syndrome (IBS).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom